Evidence for a purifying selection acting on the β-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus by Milheiriço, Catarina et al.
RESEARCH ARTICLE Open Access
Evidence for a purifying selection acting on the
b-lactamase locus in epidemic clones of
methicillin-resistant Staphylococcus aureus
Catarina Milheiriço
1, Ana Portelinha
2, Ludwig Krippahl
3, Hermínia de Lencastre
1,4 and Duarte C Oliveira
1,2*
Abstract
Background: The b-lactamase (bla) locus, which confers resistance to penicillins only, may control the transcription of
mecA, the central element of methicillin resistance, which is embedded in a polymorphic heterelogous chromosomal
cassette (the SCCmec element). In order to assess the eventual correlation between bla allotypes and genetic lineages,
SCCmec types and/or b-lactam resistance phenotypes, the allelic variation on the bla locus was evaluated in a
representative collection of 54 international epidemic methicillin-resistant Staphylococcus aureus (MRSA) clinical strains
and, for comparative purposes, also in 24 diverse methicillin-susceptible S. aureus (MSSA) strains.
Results: Internal fragments of blaZ (the b-lactamase structural gene) were sequenced for all strains. A subset of
strains, representative of blaZ allotypes, was further characterized by sequencing of internal fragments of the blaZ
transcriptional regulators, blaI and blaR1. Thirteen allotypes for blaZ, nine for blaI and 12 for blaR1 were found. In a
total of 121 unique single-nucleotide polymorphisms (SNP) detected, no frameshift mutations were identified and
only one nonsense mutation within blaZ was found in a MRSA strain. On average, blaZ alleles were more
polymorphic among MSSA than in MRSA (14.7 vs 11.4 SNP/allele). Overall, blaR1 was the most polymorphic gene
with an average of 24.8 SNP/allele. No correlation could be established between bla allotypes and genetic lineages,
SCCmec types and/or b-lactam resistance phenotypes. In order to estimate the selection pressure acting on the bla
locus, the average dN/dS values were computed. In the three genes and in both collections dN/dS ratios were
significantly below 1.
Conclusions: The data strongly suggests the existence of a purifying selection to maintain the bla locus fully
functional even on MRSA strains. Although, this is in agreement with the notion that in most clinical MRSA strains
mecA gene is under the control of the bla regulatory genes, these findings also suggest that the apparently
redundant function of blaZ gene for the MRSA resistant phenotype is still important for these strains. In addition,
the data shows that the sensor-inducer blaR1 is the primary target for the accumulation of mutations in the bla
locus, presumably to modulate the response to the presence of b-lactam antibiotic.
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Background
Staphylococcus aureus is a leading cause of nosocomial
infections and has recently emerged as a community
acquired pathogen [1-3]. S. aureus is also a paradigm of
adaptive power to antimicrobial chemotherapy, able to
develop resistance to virtually all classes of antibiotics
[4].The acquisition of resistance to b-lactam antibiotics
is particularly relevant in clinical terms. Although b-lac-
tams (i.e. penicillin G) were the first class of large-spec-
trum antibiotics to be introduced into clinical practice,
they are still the most widely used due to their high
effectiveness, low cost, ease of delivery and minimal side
effects [5].
In response to b-lactam chemotherapy, S. aureus has
sequentially acquired two resistance genes: first blaZ,
which codes for a b-lactamase and confers resistance to
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penicillin-binding protein (PBP2a) with reduced affinity
for virtually all b-lactams [6,7]. The transcription of both
resistance genes may be controlled by homologous two-
component systems consisting on a sensor-inducer
(BlaR1 and MecR1) and a repressor (BlaI and MecI).
Interestingly, in spite of the cross-resistance to virtually
all b-lactams provided by mecA, the great majority (>
95%) of contemporary MRSA are still positive for the b-
lactamase locus [8]. Moreover, the regulators of blaZ,
BlaR1 and BlaI, can efficiently induce mecA transcription
and, do it faster than the “natural” mecA regulators,
MecR1 and MecI [9,10]. In addition, since many MRSA
strains do not have functional mecI-mecR1 genes due to
polymorphisms in the mecA regulatory region [11], the
mecA transcription is presumably under the control of
the blaI-blaR1 genes only. In line with these observa-
tions, the presence of the blaZ locus has been shown to
promote mecA acquisition and stabilization [12,13].
In S. aureus,t h eb-lactamase genes may be located in
a plasmid or mobilized into the chromosome by trans-
poson Tn552 [14]. In contrast to the diversity of b-lacta-
mase genes found in gram-negative bacteria, all
staphylococcal enzymes studied so far are molecular
class A serine b-lactamases placed in functional group
2a [8]. The mature form of the enzyme has a molecular
mass of 30 kDa, contains 257 amino acids, and is
secreted extracellularly [15]. In 1965, Richmond pro-
posed the subdivision of staphylococcal b-lactamases in
four serotypes [16], but the structural basis of the dis-
tinction between types is still uncertain and no clear
relationship between sequence and serotype was found
[17]. Interestingly, serotypes were shown to have specific
geographic distributions [8], which may suggest a rela-
tionship between bla-type and genetic lineage. Recently,
Olsen et al have studied the allelic variation of the blaZ
gene among several staphylococcal species and 11 BlaZ
protein types were identified [14]. The multiple-
sequence alignment of those sequence types suggest a
separate evolution for plasmid- and chromosomally-
encoded blaZ and a very low frequency for exchange of
the b-lactamase locus between strains and species.
In evolutionary terms, MRSA may be regarded as a
recent sub-branch of the S. aureus population which has
acquired the heterelogous chromosomal cassette con-
taining the mecA gene - the SCCmec element [18].
Molecular epidemiology studies on large collections of
MRSA isolates have clearly shown that MRSA has a
strong clonal structure and that very few lineages,
defined by specific macro-restriction patterns of chro-
mosomal DNA and/or multi-locus sequence types,
account for the great proportion of MRSA infections
worldwide [19,20]. The clonal structure of MRSA popu-
lation may result from a “host barrier” for the mecA
acquisition, which restricts the number of acquisitions
to few more permissive lineages [13,21] and/or from the
clonal expansion of previously highly epidemic (MSSA)
lineages, which have acquired the mecA gene. Recent
data based on comparative genomics of MRSA lineages
[22-24] supports both mechanisms as it seems that,
within the same genetic (epidemic) lineage, SCCmec
acquisitions may occur continuously at the local level.
In spite of the several lines of evidence suggesting an
important role of the bla locus in the acquisition, stabili-
zation and regulation of the mecA gene, the variability of
bla genes at the sequence level has never been evaluated
among pandemic MRSA lineages. The present study was
conducted in order to evaluate the allelic variability of b-
lactamase locus in a representative collection of interna-
tionally epidemic MRSA clones and also, for comparative
purposes, in a diverse collection of methicillin-susceptible
S. aureus strains (MSSA), in an attempt to make evolu-
tionary correlations between b-lactamase allotypes and
b-lactam resistance phenotypes (i.e. MRSA vs MSSA),
SCCmec types and/or genetic lineages.
Methods
Strain collection
S. aureus strains used in the present study are listed in
Tables 1 (MRSA) and 2 (MSSA). All strains have been
previously assigned to genetic lineages by Pulse-field gel
electrophoresis (PFGE), multi-locus sequence typing
(MLST) and protein A sequence typing (spa typing).
MRSA strains have been additionally characterized in
terms of their SCCmec types. The presence of a func-
tional b-lactamase locus was confirmed by nitrocefin
disks (Sigma) for all strains, in the presence and absence
of an inducer (oxacillin at 0.05 mg/L).
Media and growth conditions
Strains were grown overnight at 37°C on tryptic soy agar
or tryptic soy broth under aerobic conditions.
DNA isolation
Total DNA was prepared using the Wizard genomic
DNA preparation kit (Promega, Madison, WI, USA),
according to the manufacturer’s recommendations,
except for the addition of lysostaphin at 0.5 mg/mL and
RNase at 0.3 mg/mL for the lysis step.
DNA amplification and sequencing
The allelic variation on the b-lactamase locus was evalu-
ated by sequencing internal fragments of blaZ and its
transcriptional regulators, blaI and blaR1, amplified by
PCR. Based on the available sequence at GenBank
(accession number: X52734) for Tn552 of S. aureus,
three pairs of primers were designed as follows (5’ ®
3’): blaZ F1, GAT AAG AGA TTT GCC TAT GC; blaZ
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Page 2 of 11Table 1 Characteristics and bla locus allotypes of the MRSA strains used in this study
Clonal complex
a) MLST (ST) SCCmec type Strain Isolation origin Isolation year bla locus alleles Ref.
blaZ blaI blaR1
247 I E2125 Denmark 1964 1 ND ND [30,31]
247 IA HPV107 Portugal 1992 1 ND ND [30,32]
247 IA BK1953 USA 1995 1 ND ND [30,33]
250 I COL UK 1965 - [30]
250 I BK793 Egypt 1961 1 1 1 [30,34]
250 IA PER34 Spain 1989 1 ND ND [30,35]
239 III ANS46 Australia 1982 1 1 1 [30,36]
239 IIIA HU25 Brazil 1993 1 ND ND [30,37]
239 IIIA HUSA304 Hungary 1993 1 ND ND [30,38]
8 239 IIIA BK2421 USA 1996 1 ND ND [30,34]
8 IVa USA300 USA 1995-2003 8 4 9 [39,40]
8 IVa USA500 USA 1995-2003 1 ND ND [39,40]
8 IVd BK2529 USA 1996 1 ND ND [30,34,39]
8 IVd BargII17 USA 1996 1 ND ND [30,39,41]
8 IVE AR43/3330.1 Ireland 1988-2002 1 1 1 [42]
8 IVh GRE120 Greece 1993 1 ND ND [39,43]
72 IVa USA700 USA 1995-2003 9 - 4 [39,40]
254 IVh HAR36 Greece 2002 1 1 1 [39,44]
770 IVb 8/6-3P Chicago 1996 3 3 6 [45]
5 I HAR21 Finland 2002 1 ND ND [44,46]
5 I-VAR PL72 Poland 1991 1 ND ND [30,47]
5 II N315 Japan 1982 8 4 9 [18]
5 II JP1 Japan 1987 8 4 9 [30,48]
5 II BK2464 USA 1996 4 6 2 [30,49]
5 II USA100 USA 1995-2003 3 3 6 [40,46]
5 IVa BM18 USA 1989 4 6 2 [30,39,50]
5 IVa FFP311 Portugal 1996 11 1 7 [39,51]
5 5 IVa HSA49 Portugal 1993 11 ND ND [39,51]
5 IVa HSA74 Portugal 1993 5 3 3 [39,51]
5 IVc Q2314 Dallas 1996 3 ND ND [52]
5 IVc USA800 USA 1995-2003 1 ND ND [39,40]
5 IVc ARG9 Argentina 1996 11 7 7 [39,51]
5 IVd JCSC4469 Japan 1982 1 1 1 [53]
5 IVg M03-68 Korea 2003 3 ND ND [54]
5I V NT COB3 Colombia 1996 6 5 10 [30,39,55]
5 VI HDE288 Portugal 1996 10 - 5 [51,56]
5 VI HUC136 Portugal 1995 10 - 5 [51,56]
228 I HAR40 Belgium 1995 2 3 1 [44,46]
30 IVc DEN2946 Denmark 2001 1 1 1 [39,57]
30 30 IVc DEN2294 Denmark 2001 1 ND ND [39,57]
36 II USA200 USA 1995-2003 1 1 1 [40,46]
36 II HAR24 Finland 2002 1 ND ND [46,47]
22 IVh HAR22 Finland 2002 9 - 4 [39,44]
22 22 IVh HGSA146 Portugal 2003 9 ND ND [39,58]
22 IVh HGSA163 Portugal 2003 9 ND ND [39,58]
45 II USA600 USA 1995-2003 7 4 9 [40,46]
45 45 IVa HAR38 Belgium 1995 6 2 8 [39,44]
45 V WIS Australia 1995 8 ND ND [59]
256 IVa CA05 Chicago 1999 8 4 9 [45]
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Page 3 of 11R1, GCA TAT GTT ATT GCT TGA CC; blaI F1, GCA
AGT TGA AAT ATC TAT GG; blaI R1, GAA AGG
ATC CAT TTT CTG TAC ACT CTC ATC; blaR1 F1,
CAT GAC AAT GAA GTA GAA GC; and blaR1 R1,
CTT ATG ATT CCA TGA CAT ACG. The predicted
amplicon sizes were 533 bp for blaZ, 484 bp for blaI
and 537 bp for blaR1.P C Rw a sp e r f o r m e di naT 1
Thermocicler (Biometra) with the following conditions:
94°C for 4 min; 30 cycles of 94°C for 30 s, 55°C for 30 s
and 72°C for 1 min; and a final extension at 72°C for 10
min. In each reaction (final volume of 50 μL), 5 ng of
chromosomal template, 2.5 U of GoTaq flexi DNA poly-
merase (Promega), 1× Colorless GoTaq flexi buffer (Pro-
mega), 2.5 mM MgCl2 (Promega), 40 μM of each
deoxynucleoside triphosphate (dNTPs mixture, Bioron)
and 20 pmol of the forward and reverse primers were
used. The amplified fragments were purified using a mix
of Exonuclease and SAP enzymes. Sequencing of both
strands was performed by Macrogen http://www.macro-
gen.com or STAB Vida http://www.stabvida.com.
Table 1 Characteristics and bla locus allotypes of the MRSA strains used in this study (Continued)
1 1 IVa MW2 USA 1998 6 2 10 [60]
1 IVa USA400 USA 1995-2003 6 2 10 [39,40]
80 80 IVc DEN2949 Denmark 2001 5 3 3 [39,57]
80 IVc DEN114 Denmark 2001 5 1 3 [39,57]
Singleton 377 V HT0184 Greece 2005 6 2 10 [61]
377 V HT0826 France 2003 6 ND ND [61]
a) Clonal complexes were determined using the E-burst software http://saureus.mlst.net/, last accessed on June 04, 2009.
ND, not determined, -, negative PCR amplification.
Table 2 Characteristics and bla locus allotypes of MSSA strains used in this study
a)
Clonal complex
b) MLST (ST) PFGE type Strain Origin Isolation date bla locus alleles
blaZ blaI blaR1
1 G IPOP38 Portugal 2001 6 2 10
1 188 L IPOP58 Portugal 2001 6 2 10
573 M HSJ109 Portugal 1995 6 2 10
5 5 C HSA29 Portugal 1992-1993 11 4 7
5 C IPOP41 Portugal 2001 6 3 6
8 8 J IPOP65 Portugal 2001 8 2 ND
615 E IPOP32 Portugal 2001 9 1 4
9 9 D HSJ122 Portugal 1995 12 1 12
10 10 Q DCC300 Portugal 1996-1997 9 1 5
12 12 X HSJ130 Portugal 1995 3 3 6
12 X Draftees728 Portugal 1996-1997 1 1 1
15 15 K HSA9 Portugal 1992-1993 6 9 ND
20 20 N HSA47 Portugal 1992-1993 6 8 11
22 22 T Draftees721 Portugal 1996-1997 6 3 5
25 25 S HSA76 Portugal 1992-1993 1 1 1
30 A IPOP37 Portugal 2001 13 1 1
30 34 B IPOP24 Portugal 2001 6 ND ND
34 B IPOP34 Portugal 2001 1 1 ND
NA B IPOP26 Portugal 2001 1 ND ND
45 45 H HSA19 Portugal 1992-1993 6 2 10
45 H IPOP56 Portugal 2001 6 ND ND
97 97 P IPOP50 Portugal 2001 6 ND ND
121 121 F IPOP44 Portugal 2001 10 1 5
Singleton 580 R DCC1185 Portugal 1996-1997 1 1 1
a) MSSA strains have been previously characterized by PFGE and MLST [62].
b) Clonal complexes were determined using the E-burst software http://saureus.mlst.net/eburst/database.asp, last accessed on June 04, 2009.
NA, not available; ND, not determined.
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reconstruction
DNA sequencing raw data analysis and multi-sequence
alignments were performed using the DNA Star soft-
ware package (Lasergene). For the multi-sequence align-
ments, the Clustal W algorithm was used. In order to
maximize sequence reads, raw sequences for blaZ and
blaR1 were trimmed immediately after the primer
sequences keeping the reading frame. As the reverse pri-
mer for blaI (BlaI R1) is located outside of the coding
region, the 3’ end of the sequence was trimmed at the
end of the coding region. For each gene, allotypes were
defined taking as reference the extant sequences of the
bla locus of Tn552, which were assigned to allotype 1.
Phylogenetic and molecular evolutionary analyses were
conducted using MEGA version 4 [25] and the resultant
phylogenetic trees were obtained using the neighbour-
joining (NJ) method with bootstrap analysis using 1000
replicates. In order to evaluate the diversity of the bla
locus, the Simpson’s indexes of diversity (SID) were cal-
culated [26,27] for each locus using the online tool
available at http://www.comparingpartitions.info. To
estimate selection pressure acting on the bla locus, we
computed the dN/dS ratios for the three genes. The
dN/dS ratios were computed for all pairs of alleles with
more than 1% substitutions, in order to give an estimate
of the divergence of the alleles while excluding those
pairs that, being too similar, would give anomalous dN/
dS ratios. The dN/dS ratios were computed by Model
Averaging, as described in [28] and implemented in the
KaKs_Calculator application [29]. This approach fits a
set of models by maximum likelihood and then com-
putes the weighted average of the models using a sec-
ond-order Akaike Information Criterion (AICC).
Nucleotide sequence accession numbers
All nucleotide sequences determined in this study were
deposited in Genbank under accession numbers
GQ980053-GQ980139 (blaZ alleles), GQ980140-
GQ980187 (blaI alleles) and GQ980188-GQ980236
(blaR1 alleles).
Results
The allelic variation in the b-lactamase locus (bla)w a s
evaluated by sequencing internal fragments of blaZ, blaI
and blaR1 genes in a representative collection of inter-
national epidemic MRSA clones and also, for compara-
tive purposes, in a diverse collection of MSSA strains.
blaZ allelic variability
Thirteen different blaZ allotypes were identified within
our collection, which comprised 54 MRSA and 24
MSSA (Tables 1 and 2, respectively). Although seven
alleles were common to MRSA and MSSA strains, we
found four alleles present in MRSA strains only and two
present in MSSA strains only. Moreover, the relative fre-
quencies of each allele were different among MRSA and
MSSA strains (Table 3); for instance, blaZ allotype 1
was dominant in MRSA strains accounting for 43% (23
out of 54) of the isolates whereas in MSSA it accounted
for 21% (5 out of 24) of the isolates, and blaZ allotype 6
was present in 11% (6 out 54) of MRSA but was domi-
nant among MSSA accounting for 46% (11 out 24) of
the isolates. The diversity of blaZ gene as measured by
the Simpson index of diversity (SID) was higher for the
MRSA collection than for MSSA, although not statisti-
cally significant due to the partial overlapping of the
confidence intervals (SID = 79.18, 95%CI 69.6-88.8 vs
SID = 76.09, 95%CI 61.3-90.9, respectively) - see Table
4. Within the length of blaZ region analyzed (492
nucleotides), we detected 43 unique single-nucleotide
polymorphisms (SNP) and on average, each blaZ allele
has 12.4 SNP comparing to the prototype blaZ sequence
of Tn552 (allele 1) - see Tables 3 and 4. Overall, blaZ
alleles were more variable in MSSA than in MRSA (14.7
and 11.4 SNP/allele, respectively). As illustrated by the
allelic frequency distribution per MRSA lineage (Figure
1) or the cluster tree of the thirteen blaZ alleles found
in our collections (Figure 2), there is no clustering
according to genetic lineages, as defined by MLST
sequence type and SCCmec type, or MSSA/MRSA phe-
notype; i.e. the same allele could be detected in different
genetic lineages or among MRSA and MSSA, and the
same lineage could be characterized by several alleles. In
addition, there was also no clear clustering of blaZ allo-
types according to geographic origin or isolation date of
the MRSA isolates (see Table 1).
The BlaZ variability in the MRSA and MSSA strains at
the protein level was evaluated by comparison of the
deduced amino acid sequence of all alleles against the
deduced amino acid sequence for the BlaZ of Tn552.
Overall, the deduced amino acid sequences of blaZ
alleles from the MRSA and MSSA strains revealed on
average 5.8 silent mutations, 1.8 conservative missense
mutations and 4 non-conservative missense mutations
per allotype (see Tables 3 and 4). For MRSA strain
HAR40, a nonsense mutation at Gln76 was detected
which presumably originates a non-functional truncated
BlaZ protein. As this strain was positive for the nitroce-
fin test, the DNA extraction and the blaZ sequencing
were repeated and the nonsense mutation was con-
firmed. No frameshift mutations were found in blaZ
allotypes.
Allelic variability of blaZ regulatory genes
Based on the blaZ variability analysis, we selected 51
representative strains to further characterize the variabil-
ity in the blaZ regulatory genes, blaI and blaR1.S o m e
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blaZ regulatory genes (see Tables 1 and 2).
Within the length of blaI region analyzed (351 nucleo-
tides), we detected 13 unique SNP, which account for
the nine blaI allotypes detected (see Tables 3 and 4).
Four of the nine blaI allotypes were present in both
MRSA and MSSA, while three blaI allotypes were found
in MRSA strains only and two in MSSA only. The SID
was higher for MRSA than for MSSA although not sta-
tistically significant (SID = 82.1, 95%CI 74.6-89.5 vs SID
= 74.2, 95%CI 60.5-87.9, respectively) (Table 4). On
average, each blaI allele has 3.4 SNP comparing to the
prototype blaI sequence of Tn552 (allele 1), and blaI
alleles were on average more polymorphic for MRSA
than for MSSA (3.9 vs 2.5 SNP per allele, respectively) -
see Tables 3 and 4.
Within the length of blaR1 region analyzed (498
nucleotides), we detected 65 unique SNP, which account
for the 12 blaR1 allotypes detected (see Tables 3 and 4).
Six of the 12 blaR1 allotypes were present in both
MRSA and MSSA, while four blaR1 allotypes were
unique for MRSA strains and two were characteristic of
MSSA strains. The SID values were virtually identical
for both MRSA and MSSA (SID = 88.8, 95%CI 83.2-
Table 3 Characteristics of bla locus alleles
Gene Allele No. Frequency SNP
c) Amino acid substitutions
MRSA
a) MSSA
b) Silent Conservative Missense Nonsense
1 0.43 0.21 0 0 0 0 0
2 0.02 0 1 0 0 1 1
3 0.07 0.04 9 4 2 2 0
4 0.04 0 9 4 2 3 0
5 0.06 0 7 2 2 3 0
6 0.11 0.46 13 8 2 3 0
blaZ 7 0.02 0 12 6 2 4 0
8 0.10 0.04 11 6 2 3 0
9 0.07 0.08 20 9 2 7 0
10 0.04 0.04 19 8 2 7 0
11 0.06 0.04 24 11 3 8 0
12 0 0.04 24 11 2 8 0
13 0 0.04 12 7 2 3 0
1 0.33 0.45 0 0 0 0 0
2 0.15 0.25 6 5 0 1 0
3 0.19 0.15 1 0 0 1 0
4 0.19 0.05 4 3 0 1 0
blaI 5 0.04 0 7 5 0 2 0
6 0.07 0 4 3 0 1 0
7 0.04 0 5 4 0 1 0
8 0 0.05 3 1 1 1 0
9 0 0.05 1 0 0 1 0
1 0.26 0.24 0 0 0 0 0
2 0.07 0 19 9 4 6 0
3 0.10 0 18 7 4 6 0
4 0.07 0.06 35 15 9 10 0
5 0.07 0.18 35 15 7 11 0
6 0.07 0.12 17 6 4 6 0
blaR1 7 0.07 0.06 24 10 7 7 0
8 0.03 0 33 12 6 12 0
9 0.16 0 31 11 6 11 0
10 0.13 0.24 32 12 6 11 0
11 0 0.06 20 9 5 7 0
12 0 0.06 34 16 6 10 0
a) The total number of MRSA strains whose blaZ, blaI and blaR1 genes were analyzed is 54, 27 and 31, respectively.
b) The total number of MSSA strains whose blaZ, blaI and blaR1 genes were analyzed is 24, 20 and 17, respectively.
c) For each allele, the SNP were counted taking as reference Tn552 bla sequences (allele 1).
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4). On average, each blaR1 allele has 24.8 SNP compar-
ing to the prototype blaR1 sequence of Tn552 (allele 1),
with no significant differences between MRSA and
MSSA (24.4 and 24.6 SNP/allele, respectively) - see
Tables 3 and 4.
In agreement with what was observed for the blaZ
gene, the cluster trees of blaI and blaR1 alleles found in
our collections also showed no clustering according to
MSSA/MRSA phenotype or genetic lineages (Figures 3
and 4). For those strains in which the alleles of the three
genes were determined, we constructed a cluster tree
with the concatenated sequences - see Figure 5. In spite
of the relatively low number of allelic profiles, there was
still no clear clustering of bla allotypes according to
MSSA/MRSA phenotype or lineage, as the same allelic
profile was present in different genetic lineages (e.g. pro-
file 8/4/9 present in clonal complexes 5, 8 and 45) and,
the same genetic lineage was characterized by profiles
from different brunches (e.g. clonal cluster 8 character-
ized by profiles 8/4/9, 1/1/1, 3/3/6, etc.).
The BlaI and BlaR1 variabilities at the protein level
in the MRSA and MSSA strains were evaluated by
comparison of the deduced amino acid sequence of
all alleles against the corresponding deduced amino
acid sequences of Tn552 (see Tables 3 and 4).
Table 4 Comparative analysis of the allelic variation in bla locus for MRSA and MSSA strains
No.
isolates
No.
alleles
Simpson’s Unique
SNP
SNP/allele
(average)
Mutations per allele (average) dN/dS
ID CI
(95%)
Silent Conserv. Missense Nonsense Average St.
dev.
blaZ 54 11 79.2 69.6-
88.8
41 11.4 5.3 1.7 3.7 0.1 0.21 0.11
MRSA blaI 27 7 82.1 74.6-
89.5
10 3.9 2.9 0 1.0 0 0.11 0.05
blaR1 31 10 88.8 83.2-
94.4
60 24.4 9.7 5.3 8.0 0 0.24 0.11
blaZ 24 9 76.1 61.3-
90.9
35 14.7 7.1 1.9 4.6 0 0.17 0.04
MSSA blaI 20 6 74.2 60.5-
87.9
9 2.5 1.5 0.2 0.8 0 0.08 0.03
blaR1 17 8 88.2 81.2-
95.3
61 24.6 10.4 5.5 7.8 0 0.24 0.10
blaZ 78 13 81.1 75.0-
87.3
43 12.4 5.8 1.8 4.0 0.1 0.20 0.10
All blaI 47 9 78.4 71.0-
85.9
13 3.4 2.3 0.1 1.0 0 0.10 0.04
blaR1 48 12 88.5 84.0-
93.0
65 24.8 10.2 5.3 8.1 0 0.25 0.10
ID, index of diversity; CI, confidence interval; SNP, single-nucleotide polymorphism; Conserv., conservative; St. dev., standard deviation
Figure 1 blaZ allotype frequency per MRSA lineage as defined
by MLST clonal cluster.
 
 
 
 
 
 
 
 
 
 
 
Strain collection  Clonal Complex 
MRSA & MSSA  5, 8, 12 
MRSA 5 
MRSA 5,  80 
MRSA & MSSA  5, 8, 12, 25, 30 
MRSA 5 
MRSA & MSSA  1, 5, 15, 20, 22, 30, 45, 97 
MSSA 30 
MRSA 45 
MRSA & MSSA  5, 8, 45 
MRSA & MSSA  8, 10, 22 
MRSA & MSSA  5, 121 
MRSA & MSSA  5 
MSSA 9 
Figure 2 Cluster tree of blaZ gene allotypes found in the MRSA
and MSSA collections. The tree was constructed with the
neighbor-joining (NJ) method. In each branch is shown the
corresponding bootstrap NJ values, taken over 1000 replicates,
which assigns confidence values for the groupings in the tree. For
each allele, it is indicated the collection(s) (MRSA or MSSA) and
genetic lineage (clonal cluster) where it was found.
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blaI alleles revealed on average 2.3 silent mutations,
0.1 conservative missense mutations and 1 non-con-
servative missense mutation per allotype. The
deduced amino acid sequences of the blaR1 alleles
showed on average 10.2 silent mutations, 5.3 conser-
vative missense mutations and 8.1 non-conservative
missense mutations per allotype. None of the SNP
detected within the blaI or blaR1 resulted in non-
sense or frameshift mutations.
Selection pressure acting on the bla locus
Based on the allelic data obtained, we computed the dN/
dS ratios as estimates for the selective pressure acting
on the bla locus. The dN/dS ratios were computed for
all pairs of alleles differing more than 1%, in order to
give an estimate of the allelic divergence, excluding the
anomalous dN/dS ratios of those pairs being very simi-
lar. The average of the obtained dN/dS values and
respective standard deviations are summarized in Table
4. The dN/dS values for the three genes in the MRSA,
MSSA and MRSA/MSSA partitions were well below 1
(between 0.08 and 0.25 with standard deviations
between 0.05 and 0.1), which suggests a negative or pur-
ifying selection acting on the bla locus. In agreement
with the average number of SNP per allele, the dN/dS
ratios were significantly higher for the blaR1 gene (0.24
- 0.25) and lower for mecI (0.08 - 0.11).
Discussion
The rationale for this study comes from several observa-
tions strongly suggesting a role of bla genes in the
acquisition, stabilization and regulation of mecA gene,
the central element of “broad-spectrum” b-lactam resis-
tance characteristic of MRSA strains. The purpose of
this study was to evaluate the allelic variability of the
bla locus in a representative collection of international
epidemic MRSA clones and also, for comparative pur-
poses, in a diverse collection of MSSA strains, in an
attempt to establish evolutionary correlations between
bla allotypes and b-lactam resistance phenotypes (i.e.
between MRSA and MSSA), SCCmec types (i.e. poly-
morphisms in the mecA regulatory locus) and/or genetic
lineages.
MRSA lineages are much less diverse than MSSA
lineages in terms of their genome content, a conse-
quence of their more recent evolutionary history [19,20]
and, apparently, also due to some “host barrier” to the
SCCmec acquisition [13]. These differences in genetic
background variability were well illustrated in our col-
lections since the international MRSA collection com-
prised eight lineages as defined by MLST clonal
complexes, whereas in the smaller and local MSSA col-
lection 15 lineages were represented.
In contrast to the genetic background diversity, we
could not detect significant differences between MSSA
and MRSA in terms of the bla locus allelic variability.
Actually, there were disparate subtle differences in
terms of number of allotypes and number of point
mutations per allotype: e.g. 11 vs 9 blaZ allotypes and
11.4 vs 14.7 SNP/allele in MRSA and MSSA, respec-
tively. These subtle differences may reflect the more
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Page 8 of 11ancient evolutionary history of MSSA or a selective
pressure to improve the bla locus activity in these
strains. That is to say, although fewer bla types have
been retained by the natural selection in MSSA, on
average, these allotypes seem to have accumulated more
adaptive mutations, in comparison to MRSA strains. In
particular for blaZ, for which differences in terms of
number of alleles and SNP/allele were more significant,
t h ep r e s e n c eo ft h ea l t e r n a t i v eb-lactam resistance
mechanism mediated by the mecA gene in MRSA
strains might have allowed a release in the selective
pressure to keep blaZ with optimal activity, in contrast
to MSSA, which rely only on blaZ-mediated resistance
to b-lactams.
No correlation could be established between bla allo-
types and strain backgrounds, b-lactam resistance phe-
notypes, strain origin and/or isolation dates, indicating
that bla genes have evolved independently from S. aur-
eus clonal lineages. This is particularly striking for
MRSA strains, which have a very strong clonal struc-
ture. These observations may be explained either by dif-
ferences in evolutionary clock speeds between the
genetic background and the bla locus or may result
from the horizontal transfer of bla genes between differ-
ent lineages, which are usually integrated in mobile ele-
ments (plasmids and composite transposons).
Interestingly, based on the characterization of a collec-
tion of several staphylococcal species, Olsen et al,s u g -
gested that there is little exchange of bla genes between
strains or species [14], which somehow contradicts our
findings. In our study, the most parsimony explanation
for the presence of the same bla type in different
genetic lineages either MRSA or MSSA or the presence
of several bla types in the same lineage, is indeed a high
frequency for the horizontal transfer of bla genes across
S. aureus clonal clusters.
In spite of the lack of evolutionary links between bla
allotypes and genetic lineages, our data strongly suggests
a selective pressure to keep the bla locus fully func-
tional, as illustrated by the calculated average dN/dS
values well below 1. This observation is valid even on
MRSA for which one could expect the accumulation of
nonsense or frameshift mutations that would render the
bla locus non-functional, due to presence of the mecA
gene. Actually, the majority of the mutational events
detected in this study were either silent or neutral muta-
tions, being the blaR1 the gene with the highest muta-
tional rate and the blaI the one with the lowest. The
increased allelic variability detected for blaR1 (in terms
of number of alleles, Simpson’s index of diversity, aver-
age SNP/allele, and dN/dS values) may suggest that this
sensor-inducer gene is the primary target for the evolu-
tionary adaptive mechanisms in the bla locus, presum-
ably to improve the induction efficiency of blaZ
expression or even mecA expression, in the case of
MRSA strains with no functional mecI-mecR1 regulatory
system. In contrast, the relatively lower variability of the
much smaller blaI gene, may suggest a fine-tuned
repressor activity and a selective pressure to maintain
the repressor activity; i.e to maintain the blaZ expres-
sion inducible.
Despite the cross-resistance to virtually all b-lactam
antibiotics provided by mecA, most contemporary
MRSA strains still carry, besides the SCCmec element,
the b-lactamase locus. This might be due to the fact
that not enough time has elapsed since the mecA acqui-
sition for MRSA strains start loosing the bla genes,
because there is a little or no fitness cost associated to
the bla genes, or because these genes may be linked to
other positively selected genes (e.g. the cadmium resis-
tance genes present in some b-lactamase plasmids).
Alternatively, the bla locus may be involved in the
“domestication” of the mecA gene, as bla genes have
been shown to stabilize the in vitro mecA acquisition
[12,13] and efficiently control mecA transcription [9,10],
explaining the “retention” of a functional bla regulatory
system by most contemporary MRSA strains [8]. Inter-
estingly, as no correlation could be established between
bla allotypes and SCCmec types, which have polymorph-
isms in the mecA regulatory locus, this maintenance of
functional blaI-blaR1 genes seems to be independent of
the functional status of the mecA “natural” regulators
mecI-mecR1.
Concerning the maintenance of a functional blaZ gene
in MRSA strains one can speculate that, even in the pre-
sence of mecA, it might be useful for the bacteria to
keep blaZ as a “first-line defense” against b-lactams. In
fact, first generation b-lactams (i.e. penicillins) are still
widely prescribed either empirically or for the treatment
of specific infections (e.g. streptococcal infections).
Moreover, penicillins have also been widely used pro-
phylactically in the livestock industry. This means that,
both in the nosocomial and community settings, MRSA
are still exposed to penicillins and, under these circum-
stances, expression of b-lactamase is enough for survival
under antibiotic pressure. From a physiological perspec-
tive, this ability to choose between the expression of two
resistance genes may be advantageous for the bacteria
since the expression of b-lactamase is likely to impose a
smaller fitness cost than the expression of PBP2a. In
fact, besides being much smaller than PBP2a (257 vs
668 amino acids), BlaZ is a secreted enzyme whereas
PBP2a is a transpeptidase protein, which must be incor-
porated into the complex cell-wall metabolism.
Conclusion
In this study we have evaluated the allelic variation of the
bla locus in MRSA and MSSA clinical strains. Although
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Page 9 of 11no correlation between bla allotypes and genetic lineages,
SCCmec types and b-lactam resistance phenotypes could
be established, we provided evidence for the existence of
a selective pressure to maintain the bla system fully func-
tional even on MRSA strains and that the sensor-inducer
gene blaR1 is the primary target for the accumulation of
adaptive mutations in the bla locus.
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